mk 912 has been researched along with efaroxan in 1 studies
Studies (mk 912) | Trials (mk 912) | Recent Studies (post-2010) (mk 912) | Studies (efaroxan) | Trials (efaroxan) | Recent Studies (post-2010) (efaroxan) |
---|---|---|---|---|---|
60 | 3 | 2 | 171 | 2 | 40 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Starke, K; Trendelenburg, AU; Wahl, CA | 1 |
1 other study(ies) available for mk 912 and efaroxan
Article | Year |
---|---|
Antagonists that differentiate between alpha 2A-and alpha 2D-adrenoceptors.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Autoreceptors; Benzofurans; Brimonidine Tartrate; Cerebral Cortex; Dioxanes; Electric Stimulation; Female; Guinea Pigs; Idazoxan; Imidazoles; Isotope Labeling; Male; Norepinephrine; Oxathiins; Quinolizines; Quinoxalines; Rabbits; Receptors, Adrenergic, alpha-2; Structure-Activity Relationship; Tritium | 1996 |